Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RELAPSING LYMPHOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 18 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Carlo Lazzaro; Manolo Beelke
      Analisi costo-efficacia di 90Y-ibritumomab tiuxetano (Zevalin) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato

      Farmeconomia e percorsi terapeutici
    2. Gregory, SA; Vose, J; Modiano, M; Kraemer, K; Rifkin, R; Rubin, A; Menduni, T; Ghalie, R
      Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin- or mitoxantrone-containing regimen

      LEUKEMIA & LYMPHOMA
    3. Hagemeister, FB; Donato, M
      Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience

      EUROPEAN JOURNAL OF HAEMATOLOGY
    4. van Besien, K; Rodriguez, A; Tomany, S; Younes, A; Donate, M; Sarris, A; Giralt, S; Mehra, R; Andersson, B; Gajewski, J; Champlin, R; Cabanillas, F
      Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

      BONE MARROW TRANSPLANTATION
    5. Villela, L; Lopez-Guillermo, A; Montoto, S; Rives, S; Bosch, F; Perales, M; Ferrer, A; Esteve, J; Colomo, L; Campo, E; Montserrat, E
      Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens

      CANCER
    6. El Helw, LM; Lorigan, PC; Robinson, MH; Coleman, RE; Hancock, BW
      VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma

      INTERNATIONAL JOURNAL OF ONCOLOGY
    7. Hanel, M; Kroger, N; Hoffknecht, MM; Peters, SO; Metzner, B; Fiedler, F; Braumann, D; Schubert, JC; Illiger, HJ; Hanel, A; Kruger, WH; Zeller, W; Weh, HJ; Hossfeld, DK; Zander, AR
      ASHAP - an effective salvage therapy for recurrent and refractory malignant lymphomas

      ANNALS OF HEMATOLOGY
    8. Hagemeister, FB
      The role of ifosfamide in the treatment of lymphomas

      LEUKEMIA & LYMPHOMA
    9. Soussain, C; Souleau, B; Gabarre, J; Zouabi, H; Sutton, L; Boccaccio, C; Albin, N; Charlotte, F; Merle-Beral, H; Delort, J; Binet, JL; Leblond, V
      Intensive chemotherapy with hematopoietic cell transplantation after ESHAPtherapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients

      LEUKEMIA & LYMPHOMA
    10. Lossos, IS; Paltiel, O; Polliack, A
      Salvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas

      LEUKEMIA & LYMPHOMA
    11. Wang, WS; Chiou, TJ; Liu, JH; Fan, FS; Yen, CC; Tung, SL; Chen, PM
      ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    12. Haim, N; Drumea, K; Epelbaum, R; Ben-Shahar, M
      Dexamethasone, cytarabine, ifosfamide, and cisplatin as salvage therapy innon-Hodgkin lymphoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    13. VOSE UM
      CURRENT APPROACHES TO THE MANAGEMENT OF NON-HODGKINS-LYMPHOMA

      Seminars in oncology
    14. GARAY G; DUPONT J; DRAGOSKY M; NUCIFORA E; CACCHIONE R; SCHNIDRIG P; FERNANDEZ J; ABELALZUETA; RIVEROS D; NOVIELLO V; BEGUELIN R; CAMPESTRI R; ALBERA C; NICASTRO M; TRIGUBOFF E
      COMBINATION SALVAGE CHEMOTHERAPY WITH MIZE (IFOSFAMIDE-MESNA, IDARUBICIN AND ETOPOSIDE) FOR RELAPSING OR REFRACTORY LYMPHOMA

      Leukemia & lymphoma
    15. RODRIGUEZMONGE EJ; CABANILLAS F
      LONG-TERM FOLLOW-UP OF PLATINUM-BASED LYMPHOMA SALVAGE REGIMENS - THEM.D.-ANDERSON-CANCER-CENTER EXPERIENCE

      Hematology/oncology clinics of North America
    16. MOHAR A; SOBREVILLACALVO P; VELASQUEZ WS
      LYMPHOMA

      Revista de Investigacion Clinica
    17. SCHMITZ N
      REPEAT TREATMENT OF HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMAS

      Der Internist
    18. HAIM N; BENSHAHAR M; FARAGGI D; TSURIETZIONI A; LEVIOV M; EPELBAUM R
      DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN AS 2ND-LINE THERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 12:19:55